Skip to main content
Have a personal or library account? Click to login
Prevalence of economic burden of overweight and obesity and their associated factors in Saudi Arabia Cover

Prevalence of economic burden of overweight and obesity and their associated factors in Saudi Arabia

Open Access
|Apr 2026

References

  1. Coker T, Saxton J, Retat L, Alswat K, Alghnam S, Al-Raddadi RM, Abdul Razack HI, Webber L, Alqahtani SA. The future health and economic burden of obesity-attributable type 2 diabetes and liver disease among the working-age population in Saudi Arabia. PloS one. 2022; 17:e0271108.
  2. Ng SW, Zaghloul S, Ali HI, Harrison G, Popkin BM. The prevalence and trends of overweight, obesity and nutrition-related non-communicable diseases in the Arabian Gulf States. Obes Rev. 2011; 12:1–3.
  3. Safiri S, Sorkhabi AD, Aletaha R, Hamidi S, Asghari KM, Sarkesh A, et al. Obesity: global epidemiology, trends, risk factors, and clinical aspects. Int J Aging. 2024; 2:e19.
  4. Murshid MY, Murshid EM, Bukhari N, Alfayez M, Salah T, Bahadur Y. The rising burden of obesity-linked cancers in Saudi Arabia: a public health review. Ann Med Surg. 2026; 88: 2335–47.
  5. Jalilzadeh M, Goharinezhad S. Exploring the multifaceted factors influencing overweight and obesity: a scoping review. Front Public Health. 2025; 13:1540756.
  6. Al-Sabah S, ElShamy A, Jois S, Low K, Gras A, Gulnar EP. The economic impact of obesity in Kuwait: a micro-costing study evaluating the burden of obesity-related comorbidities. J Med Econ. 2023; 26:1368–76.
  7. Valdez GF, Ajzoon M, Al Zuwameri N. A scoping review of the biological, socioeconomic and environmental determinants of overweight and obesity among Middle Eastern and Northern African nationalities. Sultan Qaboos Univ Med J. 2024; 24:20.
  8. Huang PF, Wang QY, Chen RB, Wang YD, Wang YY, Liu JH, et al. A new strategy for obesity treatment: revealing the frontiers of anti-obesity medications. Curr Mol Med. 2025; 25:13–26.
  9. Mechanick JI, Butsch WS, Christensen SM, Hamdy O, Li Z, Prado CM, et al. Strategies for minimizing muscle loss during use of incretin-mimetic drugs for treatment of obesity. Obes Rev. 2025; 26:e13841.
  10. Shi Q, Wang Y, Hao Q, Vandvik PO, Guyatt G, Li J, et al. Pharmacotherapy for adults with overweight and obesity: a systematic review and network meta-analysis of randomised controlled trials. Lancet. 2024; 403:e21–31.
  11. Alshehri FS, Alorfi NM. Saudi adults’ understanding and views of weight management practices and obesity. Diabetes Metab Syndr Obes. 2023; 16:3513–31.
  12. Nagi MA, Almalki ZS, Thavorncharoensap M, Sangroongruangsri S, Turongkaravee S, Chaikledkaew U, et al. The burden of obesity in Saudi Arabia: a real-world cost-of-illness study. Clinicoecon Outcomes Res. 2025; 17:233–46.
DOI: https://doi.org/10.2478/abm-2026-0013 | Journal eISSN: 1875-855X | Journal ISSN: 1905-7415
Language: English
Page range: 123 - 129
Published on: Apr 30, 2026
In partnership with: Paradigm Publishing Services
Publication frequency: 6 issues per year

© 2026 Mubashir Zafar, Abdullah Ali Albrahimi, Naif Mohammed Salem Alanezi, published by Chulalongkorn University
This work is licensed under the Creative Commons Attribution 4.0 License.